WST logo

WST

Profile

Full Name

West Pharmaceutical Services, Inc.

Ticker Symbol

WST

Exchange

NYSE

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

March 17, 1980

Indexes

S&P 500

Website

http://www.westpharma.com

Employees

10600

Key Details

Price

$218.80(-0.03%)

Market cap

Last Dividend

$0.21

TTM Dividend yield

0.38%

Annual revenue

$2.89B(-1.92% YoY)

Annual EPS

$6.69(-15.10% YoY)

PE ratio

34.35

Next earnings date

Jul 25, 2025

Next ex-dividend date

Jul 30, 2025

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $218.80
    WST price is $218.80

    30-Day Relative Volume

    0.79
    WST 30-day relative volume is 0.79

    Price Performance

    Price Today change

    -0.03%
    WST price is down -0.03% today

    Price YTD change

    -33.2%
    WST price is down -33.2% since January 1st

    Price 1-year change

    -33.57%
    WST price is down -33.57% year-on-year

    Price 3-year change

    -27.64%
    WST price is down -27.64% over the past 3 years

    Price Range

    Price All-time high

    $475.35
    WST price is currently -53.97% below its historical high of $475.35

    Price 3-year low

    $187.43
    WST price is currently +16.74% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $15.72B
    WST market capitalization is $15.72 billion

    Market cap 3-year change

    -29.75%
    WST market capitalization is down -29.75% over the past 3 years

    Market cap All-time high

    $34.92B
    WST market capitalization is currently -54.98% below its historical high of $34.92 billion

    Market cap sector rank

    94.68%
    WST market capitalization is higher than 94.68% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -1.37%
    WST shares outstanding is down -1.37% year-on-year

    Shares Outstanding 3-Year Change

    -3.01%
    WST shares outstanding is down -3.01% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.54
    WST beta is 0.54

    200-day SMA

    $270.96
    WST price is currently -19.25% below its 200-day simple moving average

    50-day SMA

    $214.90
    WST price is currently +1.82% above its 50-day simple moving average

    RSI

    51.09
    WST 14-day relative strength index is 51.09

    Volume

    0.79
    WST 30-day relative volume is 0.79

    ATR

    $5.25
    WST average true range is $5.25

    10-day Historical Volatility

    22.98%
    WST 10-day historical volatility is 22.98%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.21
    WST last dividend was $0.21 per share, with an ex-dividend date of April 30, 2025

    Next Dividend

    $0.21
    WST has announced a dividend of $0.21 per share, with an ex-dividend date set for July 30, 2025

    Dividend per share

    Dividend per share

    $0.81
    WST annual dividend per share is $0.81

    Dividend per share Sector Rank

    32.94%
    WST annual dividend per share is higher than 32.94% of companies in Healthcare sector

    Dividend per share 1-Year Change

    +5.19%
    WST annual dividend per share is up +5.19% year-on-year

    Dividend per share 3-Year Change

    +17.39%
    WST annual dividend per share is up +17.39% over the past 3 years

    Dividend yield

    Dividend yield

    0.37%
    WST annual dividend yield is 0.37%

    Dividend yield Sector Rank

    8.33%
    WST annual dividend yield is higher than 8.33% of companies in Healthcare sector

    Other

    Payout ratio

    12.00%
    WST annual payout ratio is 12.00%

    Dividends paid

    $59.10M
    WST annual dividends paid is $59.10 million

    Free cash flow

    $276.40M
    WST annual free cash flow is $276.40 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $2.89B
    WST annual revenue is $2.89 billion

    Revenue Analysts estimate

    $2.96B
    WST annual revenue is currently -2.29% lower than the consensus analysts' forecast

    Revenue 1-year change

    -1.92%
    WST annual revenue is down -1.92% year-on-year

    Revenue Sector rank

    88.24%
    WST annual revenue is higher than 88.24% of companies in Healthcare sector

    EPS

    EPS

    $6.69
    WST annual earnings per share is $6.69

    EPS Analysts estimate

    $6.30
    WST annual earnings per share is currently +6.25% higher than the consensus analysts' forecast

    EPS 1-year change

    -15.1%
    WST annual earnings per share is down -15.1% year-on-year

    EPS Sector rank

    96.71%
    WST annual earnings per share is higher than 96.71% of companies in Healthcare sector

    Profit

    Gross profit

    $998.50M
    WST annual gross profit is $998.50 million

    Gross margin

    34.51%
    WST annual gross profit margin is 34.51%

    Operating profit

    $569.90M
    WST annual operating income is $569.90 million

    Operating margin

    19.70%
    WST annual operating profit margin is 19.70%

    Net income

    $492.70M
    WST annual net profit is $492.70 million

    Net margin

    17.03%
    WST annual net profit margin is 17.03%

    Expenses

    Total expenses

    $2.32B
    WST annual total expenses is $2.32 billion

    Operating expenses

    $428.60M
    WST annual total operating expenses is $428.60 million

    Cost of goods sold

    $1.89B
    WST annual cost of goods sold is $1.89 billion

    Selling, general & administrative expenses

    $338.50M
    WST annual SGA is $338.50 million

    Depreciation and amortization

    $155.40M
    WST annual depreciation & amortization is $155.40 million

    Interest expense

    $3.00M
    WST annual interest expense is $3.00 million

    Income tax

    $107.50M
    WST annual income tax is $107.50 million

    EBIT & EBITDA

    EBIT

    $569.90M
    WST annual earnings before interest & taxes is $569.90 million

    EBITDA

    $725.30M
    WST annual EBITDA is $725.30 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $3.64B
    WST annual total assets is $3.64 billion

    Non current assets

    $2.11B
    WST annual long term assets is $2.11 billion

    Current assets

    $1.41B
    WST annual total current assets is $1.41 billion

    Cash and cash equivalents

    $484.60M
    WST annual cash & cash equivalents is $484.60 million

    Accounts receivable

    $552.50M
    WST annual accounts receivable is $552.50 million

    Inventory

    $377.00M
    WST annual inventory is $377.00 million

    Liabilities

    Total liabilities

    $961.10M
    WST annual total liabilities is $961.10 million

    Long term liabilities

    $410.70M
    WST annual total long term liabilities is $410.70 million

    Current liabilities

    $239.30M
    WST annual total current liabilities is $239.30 million

    Accounts payable

    $239.30M
    WST annual accounts payable is $239.30 million

    Debt

    Total debt

    $302.30M
    WST annual total debt is $302.30 million

    Total debt 1-year change

    -2.17%
    WST annual total debt is down -2.17% year-on-year

    Long term debt

    $284.40M
    WST annual long term debt is $284.40 million

    Short term debt

    $17.90M
    WST annual short term debt is $17.90 million

    Equity & Capital

    Shareholders equity

    $2.68B
    WST annual stockholders equity is $2.68 billion

    Book value

    $2.68B
    WST annual book value is $2.68 billion

    Retained earnings

    $3.96B
    WST annual retained earnings is $3.96 billion

    Working capital

    $1.17B
    WST annual working capital is $1.17 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $653.40M
    WST annual cash flow from operations is $653.40 million

    Cash from operations 1-year change

    -15.85%
    WST annual cash flow from operations is down -15.85% year-on-year

    Cash from investing

    -$378.70M
    WST annual cash flow from investing activities is -$378.70 million

    Cash from investing 1-year change

    -2.71%
    WST annual cash flow from investing activities is down -2.71% year-on-year

    Cash from financing

    -$622.60M
    WST annual cash flow from financing activities is -$622.60 million

    Cash from financing 1-year change

    -35.47%
    WST annual cash flow from financing activities is down -35.47% year-on-year

    CAPEX

    CAPEX

    $377.00M
    WST annual capital expenditures is $377.00 million

    CAPEX 1-year change

    +4.14%
    WST annual capital expenditures is up +4.14% year-on-year

    Free Cash Flow

    Free cash flow

    $276.40M
    WST annual free cash flow is $276.40 million

    Free cash flow 1-year change

    -33.32%
    WST annual free cash flow is down -33.32% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    34.51%
    WST annual gross profit margin is 34.51%

    Operating margin

    19.70%
    WST annual operating profit margin is 19.70%

    Net margin

    17.03%
    WST annual net profit margin is 17.03%

    ROA & ROE

    ROA

    13.19%
    WST annual return on assets is 13.19%

    ROE

    17.71%
    WST annual return on equity is 17.71%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    34.35
    WST price to earnings ratio is 34.35

    PE ratio Sector rank

    64.02%
    WST price to earnings ratio is higher than 64.02% of companies in Healthcare sector

    PB Ratio

    PB ratio

    5.86
    WST price to book ratio is 5.86

    PB ratio Sector rank

    83.21%
    WST price to book ratio is higher than 83.21% of companies in Healthcare sector

    PS Ratio

    PS ratio

    5.43
    WST price to sales ratio is 5.43

    PS ratio Sector rank

    65.56%
    WST price to sales ratio is higher than 65.56% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $15.62B
    WST enterprise value is $15.62 billion

    Enterprise value Sector rank

    93.9%
    WST enterprise value is higher than 93.9% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    21.39
    WST EV/EBITDA is 21.39

    EV/EBITDA Sector rank

    92.25%
    WST EV/EBITDA is higher than 92.25% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    5.91
    WST annual current ratio is 5.91

    Quick ratio

    4.33
    WST annual quick ratio is 4.33

    Leverage

    Debt to equity

    0.00
    WST annual debt to equity ratio is 0.00

    Interest coverage ratio

    189.97
    WST annual interest coverage ratio is 189.97

    Risk & Stability

    Piotroski F-Score

    8
    WST piotroski f-score is 8

    Altman Z-Score

    13.03
    WST altman z-score is 13.03

    Analyst ratings

    Recent major analysts updates

    Mar 18, 25 Evercore ISI Group
    Outperform
    Feb 14, 25 Keybanc
    Overweight
    Jan 8, 25 Citigroup
    Buy
    Dec 13, 24 Wolfe Research
    Peer Perform
    Dec 13, 24 B of A Securities
    Buy
    Dec 12, 24 UBS
    Buy
    Feb 16, 24 UBS
    Neutral
    Feb 13, 24 Keybanc
    Overweight
    Feb 7, 24 Jefferies
    Buy
    Oct 27, 23 Stephens & Co.
    Overweight

    Institutional Ownership

    Screeners with WST included

    US stocks
    High Piotroski score stocks
    S&P 500 companies earnings calendar
    Stocks below SMA 200
    Most recommended stocks
    S&P 500 companies
    Stocks below analysts price target
    S&P 500 companies dividend calendar
    Healthcare sector
    Companies with growing dividends
    • What is the ticker symbol for West Pharmaceutical Services?
    • Does West Pharmaceutical Services pay dividends?
    • What sector is West Pharmaceutical Services in?
    • What industry is West Pharmaceutical Services in?
    • What country is West Pharmaceutical Services based in?
    • When did West Pharmaceutical Services go public?
    • Is West Pharmaceutical Services in the S&P 500?
    • Is West Pharmaceutical Services in the NASDAQ 100?
    • Is West Pharmaceutical Services in the Dow Jones?
    • When was West Pharmaceutical Services's last earnings report?
    • When does West Pharmaceutical Services report earnings?
    • Should I buy West Pharmaceutical Services stock now?

    What is the ticker symbol for West Pharmaceutical Services?

    The ticker symbol for West Pharmaceutical Services is NYSE:WST

    Does West Pharmaceutical Services pay dividends?

    Yes, West Pharmaceutical Services pays dividends. The last payment was $0.21, with an ex-dividend date on April 30, 2025

    What sector is West Pharmaceutical Services in?

    West Pharmaceutical Services is in the Healthcare sector

    What industry is West Pharmaceutical Services in?

    West Pharmaceutical Services is in the Medical Instruments & Supplies industry

    What country is West Pharmaceutical Services based in?

    West Pharmaceutical Services is headquartered in United States

    When did West Pharmaceutical Services go public?

    West Pharmaceutical Services's initial public offering (IPO) was on March 17, 1980

    Is West Pharmaceutical Services in the S&P 500?

    Yes, West Pharmaceutical Services is included in the S&P 500 index

    Is West Pharmaceutical Services in the NASDAQ 100?

    No, West Pharmaceutical Services is not included in the NASDAQ 100 index

    Is West Pharmaceutical Services in the Dow Jones?

    No, West Pharmaceutical Services is not included in the Dow Jones index

    When was West Pharmaceutical Services's last earnings report?

    West Pharmaceutical Services's most recent earnings report was on Apr 24, 2025

    When does West Pharmaceutical Services report earnings?

    The next expected earnings date for West Pharmaceutical Services is Jul 25, 2025

    Should I buy West Pharmaceutical Services stock now?

    As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page